Jabil CEO Kenny Wilson, still in his first year at the helm of the $14.4 billion technology manufacturing company, has been benched due to an investigation into his conduct, the company said in a ...

After a four-week internal investigation at $14 billion electronics manufacturer Jabil Inc., CEO Kenneth “Kenny” Wilson has abruptly resigned just after passing his one-year anniversary at the ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

BofA raised the firm’s price target on Jabil (JBL) to $180 from $165 and keeps a Buy rating on the shares. After having hosted an investor call ...

An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...